Prognostic value of urinary 11-dehydro-thromboxane B2 for mortality: A cohort study of stable coronary artery disease patients treated with aspirin
Catheterization and Cardiovascular Interventions Dec 05, 2017
Vasudevan A, et al. - This study was implemented to assess the optimal cut point of urinary 11-dehydro-thromboxane B2 (11dhTxB2) for the risk of mortality in aspirin-treated coronary artery disease (CAD) patients. In this patient population, 1597.8 (pg/mg) was identified as the optimal cut point for urine 11dhTxB2 for the risk prediction of mortality over 5 years.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
